Targeting and reducing neuronal ceramide overaccumulation in 5xFAD mice improves AD pathologies and cognitive function
Joseph L Wilkerson, Amandine Chaix, Scott A Summers, William L Holland · 2025
Read Targeting and reducing neuronal ceramide overaccumulation in 5xFAD mice improves AD pathologies and cognitive function by Joseph L Wilkerson, Amandine Chaix, Scott A Summers, William L Holland (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710691.txt.
Description
Joseph Wilkerson and co-authors test whether cutting a fat called ceramide in brain cells can ease Alzheimer's disease in mice. Their 2025 study uses a mouse strain bred to show the disease's plaques. Ceramide piles up in the plaques and fluids of patients, yet lowering it had rarely been tried as a treatment.
The team attacked the build-up in two ways. A drug blocked the making of new ceramide, in mice fed plain food and in mice fed a rich diet that drives ceramide up. A gene tweak made nerve cells break ceramide down, started either early in life or once the disease was mature. The team then read plaque load, the state of support cells, and how well the mice thought.
Catalog record
| CREATOR | Joseph L Wilkerson, Amandine Chaix, Scott A Summers, William L Holland |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |